Platinum Drug Shortage Impacts Patients with Thymic Cancer

FOR IMMEDIATE RELEASE: June 17, 2023 THYMIC CARCINOMA CENTER CALLS FOR ACTION AMID NATIONWIDE SHORTAGE OF CRITICAL CHEMOTHERAPY DRUGS CARBOPLATIN AND CISPLATIN OLATHE, KANSAS – The Thymic Carcinoma Center (TCC), an organization dedicated to supporting those battling thymic carcinoma, is deeply concerned about the nationwide shortage of the platinum-based chemotherapy drugs, carboplatin and cisplatin. The shortage has impacted cancer treatment

Skip to content